Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,664
Total Claims
$2.0M
Drug Cost
1,119
Beneficiaries
$1,803
Cost/Patient
Risk Score Breakdown 14/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+16%
Opioid rate vs peers
2.6% vs 2.2% avg
+28%
Cost per patient vs peers
$1,803 vs $1,411 avg
+77%
Brand preference vs peers
18.8% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
2.6%
Opioid Rate
276
Opioid Claims
$64K
Opioid Cost
17.0%
Long-Acting Rate
Brand vs Generic
Brand: 1,965 claims · $1.7M
Generic: 8,506 claims · $311K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 132 | $230K |
| Semaglutide | 114 | $202K |
| Sitagliptin Phosphate | 90 | $149K |
| Dulaglutide | 59 | $132K |
| Semaglutide | 44 | $74K |
| Bictegrav/Emtricit/Tenofov Ala | 14 | $67K |
| Apixaban | 50 | $61K |
| Oxycodone Hcl/Acetaminophen | 12 | $55K |
| Dapagliflozin Propanediol | 30 | $54K |
| Rivaroxaban | 48 | $52K |
| Sitagliptin Phos/Metformin Hcl | 33 | $45K |
| Fluticasone Propion/Salmeterol | 62 | $42K |
| Insulin Glargine,hum.Rec.Anlog | 58 | $40K |
| Linaclotide | 36 | $32K |
| Budesonide/Formoterol Fumarate | 57 | $27K |
Prescribing Profile
Patient Profile
71
Avg Age
66%
Female
1.41
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data